Ro, a direct-to-consumer telehealth app for pharmacy services, is valued at $500 million, TechCrunch reports.
Venture capitalists have valued the telehealth business at $500 million after various fundraising series since the company launched in 2017, according to the report.
Ro is the parent company of telehealth apps Roman, which provides services for men experiencing issues like erectile dysfunction, as well as Rory, which comprises products for menopausal women.
The telehealth parent also leads a digital health brand, called Zero, which aims to help customers quit smoking. Zero offers prescription cessation medication as well as a mobile app for users to track their progress.